What You Should Know:
- Signos, a metabolic and weight management company, has announced the launch of the Signos Glucose Monitoring System.
- The system is the first FDA-cleared, over-the-counter glucose monitoring system for weight management. It is also the first non-pharmacological approach cleared by the FDA for glucose management that not only helps those who are overweight but also helps prevent those who are at-risk.
Enterprise-Grade Capabilities, Consumer-Friendly
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Living Optics and NVIDIA Jetson Showcase Real-Time Hyperspectral Imaging
What You Should Know:
- Living Optics, a leader in hyperspectral imaging (HSI), has announced its latest real-time blood perfusion demonstration, which was built on the NVIDIA Jetson platform. The demonstration offers a glimpse into the future of edge AI for healthcare, life sciences, and precision imaging.
- The live demo showcases how the company’s spectral vision technology can distinguish between oxygenated and deoxygenated blood in real-time. This capability provides critical
Read More
M&A: Remedy Meds Acquires Thirty Madison in All-Stock Deal Valued at over $500M
What You Should Know:
- Remedy Meds, LLC, a consumer virtual-care and pharmacy platform, today announced it has entered into a definitive agreement to acquire Thirty Madison, Inc. ("Thirty Madison").
- The transaction creates a larger, multi-brand platform across women's, men's, and metabolic health. The transaction, which is valued just north of $500M, will be funded through an all-stock deal.
Expanding Access Through a Unified Multi-Brand Ecosystem
Thirty Madison, a leading
Read More
MedTech M&A Surges in 2025: Why Startups Are Now Ripe for Acquisition
After a few mixed years in medical technology (MedTech) mergers and acquisition (M&A) activity, 2025 is shaping up to be a landmark year, particularly among cash-rich medical device strategics. In Q1 2025, there were 57 MedTech M&A transactions totaling $9.2 billion, compared to 62 deals worth $2.7 billion in Q1 2024, according to J.P. Morgan’s MedTech sector report.
First quarter venture capital (VC)
Read More
Parasym Launches Nuropod, a Non-Invasive Vagus Nerve Stimulation Device
What You Should Know:
- Parasym has launched Nuropod, the first ear-based, clinically studied vagus nerve stimulation (VNS) device in the U.S. that does not require surgery.
- The wearable device is designed to reduce symptoms such as persistent fatigue, anxious states, and markers related to inflammation by activating the vagus nerve to restore the body’s "rest and digest" state. The device is backed by more than 50 completed clinical studies.
A Non-Surgical Alternative
Read More
Senseonics to Take Over Eversense 365 Commercialization from Ascensia
What You Should Know:
- Senseonics Holdings, a medical technology company specializing in implantable continuous glucose monitoring (CGM) systems, has announced a Memorandum of Understanding (MOU) with Ascensia Diabetes Care to transition all global commercialization and distribution of its Eversense 365 and future products to Senseonics. Since 2020, Ascensia, a member of PHC Group, has held the exclusive worldwide distribution rights for Eversense products.
This strategic move is
Read More
NewDays Secures $7M to Expand AI-Powered Cognitive Health Program to Texas
What You Should Know:
- NewDays, a company offering a science-backed cognitive health treatment program, has announced an oversubscribed $7M seed funding round from General Catalyst and Madrona.
- The company is also expanding its services to Texas, following a successful pilot phase in California, Washington, and Florida. The expansion aims to address the significant challenge of cognitive impairment in the U.S., where 1 in 3 people over the age of 65 have a serious cognitive
Read More
ArcaScience Raises $7M to Advance AI-Powered Drug Benefit-Risk Evaluation
What You Should Know:
- ArcaScience, a Paris, France-based AI Healthtech startup, has announced a $7M seed funding round led by The Moon Venture, with participation from Pléiade Venture, Plug&Play Ventures, Bpifrance, and AKKA Technologies. This marks the company's first institutional funding round, following a €1.3 million pre-seed raise.
- The new funds will be used to expand operations in the U.S. and U.K., launch the company’s first patient-facing solution, and strategically
Read More
WellSpan Health and General Catalyst Partner to Transform Healthcare Delivery
What You Should Know:
- WellSpan Health and General Catalyst’s Health Assurance Transformation Company (HATCo) have announced an expanded collaboration.
- The new initiative builds on a strategic partnership that began in 2023, with WellSpan Health becoming the first Transformation Partner to HATCo. The two organizations will work together to modernize and transform healthcare delivery through the development of new AI technologies.
Targeting Three Critical Areas of
Read More
Medable Launches Agent Studio, the First Agentic AI Platform for Life Sciences
What You Should Know:
- Medable, a technology provider for clinical development, has launched Agent Studio, which it calls the industry's first agentic AI platform purpose-built for life sciences.
- Agent Studio is a no-code agent-builder that allows clinical teams to quickly custom-configure AI agents. Medable also introduced CRA Agent, a pre-built agent designed for clinical trial monitoring that runs on the Agent Studio platform. Both Agent Studio and CRA Agent are intended
Read More
